PegBio Co., Ltd. (HKG:2565)
64.60
+0.40 (0.62%)
At close: Feb 27, 2026
PegBio Market Cap
PegBio has a market cap or net worth of 25.26 billion as of February 27, 2026.
Market Cap
25.26B
Enterprise Value
25.00B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
64.60
Market Cap Chart
Since May 27, 2025, PegBio's market cap has increased from 4.46B to 25.26B, an increase of 466.26%. That is a compound annual growth rate of 890.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 25.26B | -6.38% |
| Dec 31, 2025 | 26.99B | 504.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 26.11B |
| InnoCare Pharma | 24.41B |
| TransThera Sciences (Nanjing) | 27.49B |
| Duality Biotherapeutics | 28.39B |
| Shanghai Junshi Biosciences | 34.98B |
| Biocytogen Pharmaceuticals (Beijing) | 35.67B |
| Shanghai Henlius Biotech | 36.44B |
| Ascentage Pharma Group International | 17.51B |